Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn’s Disease: Prospective Real-World Experience-Reference-Cited by-同舟云学术

Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn’s Disease: Prospective Real-World Experience

Published:2023-07 Issue:7 Volume:21 Page:1913-1923.e2
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Friedberg Scott,Choi David,Hunold Thomas,Choi Natalie K.,Garcia Nicole M.,Picker Emma A.,Cohen Nathaniel A.,Cohen Russell D.,Dalal Sushila R.,Pekow Joel,Sakuraba Atsushi,Krugliak Cleveland Noa,Rubin David T.^ORCID

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference13 articles.

1. Upadacitinib for Crohn’s disease and ulcerative colitis treatment: hitting the selective JAKpot;Parigi;Gastroenterology,2021

2. Entering the era of disease modification in inflammatory bowel disease;Hart;Gastroenterology,2022

3. Tofacitinib for induction and maintenance therapy of Crohn’s disease: results of two phase IIb randomised placebo-controlled trials;Panés;Gut,2017

4. Real-world experience with tofacitinib in IBD at a tertiary center;Weisshof;Dig Dis Sci,2019

5. In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494);Parmentier;BMC Rheumatol,2018

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic inhibition of the JAK-STAT pathway in the treatment of inflammatory bowel disease;Cytokine & Growth Factor Reviews;2024-10

2. Game changer: How Janus kinase inhibitors are reshaping the landscape of ulcerative colitis management;World Journal of Gastroenterology;2024-09-21

3. The Successful Use of Upadacitinib as Monotherapy for Hidradenitis Suppurativa and Ulcerative Colitis in the Setting of Refractory Disease;Pediatric Dermatology;2024-09-11

4. Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib;Digestive Diseases and Sciences;2024-09-09

5. Small Molecule Therapy for Inflammatory Bowel Disease: JAK Inhibitors and S1PR Modulators;The Korean Journal of Gastroenterology;2024-08-25